Back to search results

Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), Hanzhou, Zhejiang, China

    Contact: Study coordinator (Peng Ye) · +86-18969976868

  • Zhejiang Cancer Hospital, Hanzhou, Zhejiang, China

    Contact: Study coordinator (Qixun Chen, PhD) · chenqixun64@163.com · +86-13958108371
    Contact: Study coordinator (Yongling Ji, PhD) · +86-13958085251

  • Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China

    Contact: Study coordinator (Weiyu Shen) · +86-13805876129
Study leads

  • Qixun Chen

    Principal Investigator

    Zhejiang Cancer Hospital

  • Yongling Ji

    Principal Investigator

    Zhejiang Cancer Hospital

View source on ClinicalTrials.gov(opens in a new tab)